Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1430, 2012-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Bevacizumab/ranibizumab: Ocular hypertension following intravitreal administration: 23 case reports
Reactions Weekly, Vol. 1, Iss. 1414, 2012-01 ,pp. :
Bevacizumab: Eye disorders following intravitreal administration: 16 case reports
Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. :
Bevacizumab: Endophthalmitis following intravitreal administration: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1380, 2011-01 ,pp. :
Bevacizumab/ranibizumab: Subretinal fibrosis following intravitreal administration: 7 case reports
Reactions Weekly, Vol. 1, Iss. 1353, 2011-01 ,pp. :